NOTOGINSENOSIDE R1, 98%, 250mg

Methyl 2-(2,6-dichloro-3-cyanopyridin-4-yl)acetate, 95.0%, 1g

(3-Fluoro-2-hydroxyphenyl)boronic acid, 95.0%, 5g

Ethyl 2-chloro-4-(methylsulfonyl)-benzoate, 25g

3-Chlorobenzylamine, 97.0%, 500g

tert-Butyl 2-(4-fluoro-2-methylphenyl)-4-oxopiperidine-1-carboxylate, 97%, 100mg

CHOLESTERYL LINOLEATE, 95%, 5g

1-Boc-4-hydroxy-2-oxo-2,5-dihydro-pyrrol, 98.0%, 50g

N,N-Diphenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 95.0%, 1g

8-BROMOISOQUINOLINE HCL, 97.0%, 1g

5-Formylthiophene-2-carbonitrile>98.0%(GC)1g

5-Methyl-4H-1,2,4-triazole-3-thiol, 97.0%, 1g

7-Bromo-3-methyl-[1,2,4]triazolo[4,3-a]pyridine, 95.0%, 250mg